Who Owns GT Biopharma Stock?
NASDAQ: GTBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 3:59 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 4.66%
- Held by insiders
- 15.67%
- Institutional holders
- 55
- Institutions 4.7%
- Insiders 15.7%
- Public and other 79.7%
Who owns GT Biopharma stock?
Institutional investors own about 4.7% of GT Biopharma's shares, spread across 55 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 15.67% of GTBP.
The largest institutional holders are Vanguard Capital Management LLC (0.73%), Geode Capital Management, LLC (0.52%) and Vanguard Fiduciary Trust Co (0.44%). Together, the top 10 institutions control 2.8% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their GTBP positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GTBP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 15.06K | 0.73% | -16.7% |
| Geode Capital Management, LLC | 10.67K | 0.52% | -9.4% |
| Vanguard Fiduciary Trust Co | 9.04K | 0.44% | 0.0% |
| HRT Financial LP | 4.29K | 0.21% | +100.0% |
| Everhart Financial Group, Inc. | 4.00K | 0.19% | +100.0% |
| Arax Advisory Partners | 3.75K | 0.18% | 0.0% |
| Opal Wealth Advisors, LLC | 3.27K | 0.16% | +100.0% |
| Northern Trust Corporation | 3.02K | 0.15% | +100.0% |
| Alongside, LLC | 2.56K | 0.12% | +100.0% |
| 49 Wealth Management, LLC | 2.56K | 0.12% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GTBP
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 15.06K | 0.73% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 6.72K | 0.33% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 2.48K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 88 | 0.00% |
Frequently asked questions
Who is the largest shareholder of GT Biopharma?
Vanguard Capital Management LLC is the largest institutional shareholder of GTBP, owning 0.73% of shares outstanding (15.06K shares) as of its latest 13F filing.
What percentage of GT Biopharma is owned by institutions?
Institutions own about 4.7% of GTBP shares and 5.5% of the public float.
How much of GT Biopharma do insiders own?
Insiders, such as officers and directors, own about 15.67% of GTBP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.